133 Participants Needed

Exercise for Peripheral Neuropathy

(CIPN Trial)

Recruiting at 103 trial locations
AO
KC
DM
DM
Overseen ByDee Murray, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Rochester NCORP Research Base
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether exercise can more effectively treat chemotherapy-induced peripheral neuropathy (CIPN) than usual drug treatments. CIPN occurs when chemotherapy damages nerves, causing symptoms like tingling and numbness. Participants will either follow a home-based exercise program (the Exercise Intervention) or continue with usual care for six weeks. Individuals who have had cancer, received certain chemotherapy drugs in the last nine months, and experience significant CIPN symptoms may qualify for the trial. As an unphased trial, this study provides a unique opportunity to explore innovative treatment options beyond standard care.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current medications, especially since the trial focuses on exercise as a treatment.

What prior data suggests that this exercise intervention is safe for treating chemotherapy-induced peripheral neuropathy?

Research has shown that exercise is generally safe for managing neuropathy symptoms. Some studies found that exercise can slow neuropathy progression by 20% in people with diabetes. This suggests exercise might also help with nerve problems caused by chemotherapy.

Exercise programs, including activities like walking and lifting weights, have improved symptoms and nerve function. This is encouraging because exercise is not only well-tolerated but also beneficial. Importantly, these studies did not report any serious side effects from exercise, making it a safer option compared to many medications.

Exercise is usually considered low-risk and is already recommended for many health conditions. Therefore, participating in a trial using exercise to help with neuropathy might be a safe choice.12345

Why are researchers excited about this trial?

Researchers are excited about the exercise intervention for peripheral neuropathy because it offers a unique approach focusing on physical activity rather than medication. Unlike standard treatments, which often involve pain relievers or anti-seizure medications, this program involves a home-based, self-directed walking and resistance exercise regimen tailored to each participant. The goal is to improve nerve function and reduce symptoms through natural means, which could provide a non-invasive alternative with fewer side effects. Additionally, incorporating tactile sensitivity tests and optional MRIs allows for detailed monitoring of changes, potentially revealing new insights into how exercise impacts nerve health.

What evidence suggests that exercise might be an effective treatment for chemotherapy-induced peripheral neuropathy?

Research has shown that exercise can significantly alleviate symptoms of chemotherapy-induced peripheral neuropathy (CIPN). One study found that patients who exercised experienced less severe CIPN symptoms than those who did not. Another review found that exercise, particularly strength and aerobic training, effectively reduces symptoms and improves muscle and joint function in individuals with peripheral neuropathy. In this trial, participants in Arm 1 will undergo an exercise intervention, which includes a home-based, self-directed, individually tailored progressive walking and resistance program. Participants in Arm 2 will receive usual care. Additionally, exercise has been shown to increase pain tolerance, making it easier to manage pain associated with neuropathy. These findings suggest that exercise can be a beneficial treatment option for reducing CIPN symptoms.16789

Who Is on the Research Team?

IR

Ian R Kleckner

Principal Investigator

University of Rochester NCORP Research Base

Are You a Good Fit for This Trial?

This trial is for adults with cancer who have nerve damage from chemotherapy, can understand English, and are expected to live at least six more months. They should be able to do some exercise and not have other health issues that make exercising unsafe. People who've had recent surgery or radiation (except hormone/biologic therapy) or already exercise regularly can't join.

Inclusion Criteria

Be able to provide written informed consent
I am currently receiving or have recently completed chemotherapy that can affect my nerves.
Be able to read and understand English
See 4 more

Exclusion Criteria

I am not planning any surgery or radiation during the study, but hormone or biological treatments are okay.
My doctor says I can't do certain exercises because of my health issues.
You are currently in an active or maintenance stage of regular exercise, as indicated on the screening form.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 6-week home-based individually tailored progressive exercise intervention or standard care

6 weeks
1 initial visit with exercise instructor, 2 booster meetings

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Exercise Intervention
Trial Overview The study is looking at whether exercise helps people with nerve damage caused by chemotherapy better than the usual drug treatments. Participants will follow a home-based walking and resistance training program designed to see if it reduces their symptoms of neuropathy.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1 (EXCAP, tactile sensitivity test, counseling)Experimental Treatment5 Interventions
Group II: Arm 2 (usual care, tactile sensitivity test)Active Control6 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Rochester NCORP Research Base

Lead Sponsor

Trials
14
Recruited
9,100+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

Exercise therapy may provide short-term benefits in reducing neuropathic symptoms and improving physical function in people with diabetic neuropathy, based on a review of 11 randomized clinical trials involving 517 participants.
However, the overall quality of evidence supporting these benefits is very low, and no significant effects were observed on psychosocial aspects of health.
Effects of exercise therapy on diabetic neuropathy: A systematic review and meta-analysis.Hernando-Garijo, I., Medrano-de-la-Fuente, R., Mingo-Gómez, MT., et al.[2023]
A study involving 87 patients with diabetic peripheral neuropathy (DPN) found that moderate intensity aerobic exercise significantly improved nerve conduction velocity and reduced neuropathy symptoms after eight weeks compared to standard care.
The results suggest that incorporating moderate aerobic exercise into treatment plans for individuals with type 2 diabetes can help slow the progression of DPN, highlighting its potential as an effective intervention.
Effect of aerobic exercise on peripheral nerve functions of population with diabetic peripheral neuropathy in type 2 diabetes: a single blind, parallel group randomized controlled trial.Dixit, S., Maiya, AG., Shastry, BA.[2022]
In a study of patients with idiopathic distal, symmetrical, axonal polyneuropathy, regular exercise was linked to a lower likelihood of experiencing painful neuropathy, suggesting that even low-intensity exercise can be beneficial.
While exercise did not significantly impact other symptoms like numbness, weakness, or balance issues, it indicates that maintaining an active lifestyle may help reduce pain in these patients.
Relation of exercise and pain in patients with idiopathic distal axonal polyneuropathies.Stewart, S., Thomas, S., Van Doormaal, PT., et al.[2021]

Citations

The Effects of Combined Exercise Training (Resistance ...Various studies indicate that resistance and aerobic training helps purge the diabetic peripheral neuropathic complications [15, 25, 26]. However, the findings ...
Effectiveness of exercise on musculoskeletal function and ...The available evidence suggests that exercise training is an effective method for improving peripheral neuropathy. Systematic review ...
A systematic review and network meta-analysisExercise can improve the symptoms of chemotherapy-induced peripheral neuropathy. Traditional pairwise meta-analyses of exercise interventions can only ...
Effectiveness of a Therapeutic Exercise Program to ...The exercises were highly effective in improving pain threshold and moderately effective in improving peripheral neuropathy symptoms at the 8-week follow-up ...
Beneficial effects of exercise on chemotherapy-induced ...Following the intervention, patients in the exercise group were found to have significantly less severe peripheral neuropathy symptoms compared to the control ...
Interventional effects of exercise on neuropathy in patients ...Some studies have shown that exercise intervention can reduce the rate of deterioration of neuropathy in diabetic patients by 20% [4]. A study ...
Effectiveness of exercise on musculoskeletal function and ...Physical training and activity in people with diabetic peripheral neuropathy: paradigm shift. Phys Ther. (2017) 97:31–43. doi: 10.2522/ptj ...
Effects of exercise programs on chemotherapy-induced ...The aim of this umbrella systematic review was to critically synthesize impact of physical exercise programs for cancer survivors with chemotherapy-induced ...
Impact of Exercise Training in Patients with Diabetic ...Exercise interventions, including aerobic, resistance, and balance training, show beneficial effects on neuropathic symptoms, nerve conduction, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security